APA

Chen Y., Chen S., Lien R., Shih C., Chao A., Chen K., Hwang Y., Wang N., Chen Y., Lee K., Chuang C., Chen T., Lai C. & Wu W. (20150401). Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. : Eye (London, England).

Chicago

Chen Y-H, Chen S-N, Lien R-I, Shih C-P, Chao A-N, Chen K-J, Hwang Y-S, Wang N-K, Chen Y-P, Lee K-H, Chuang C-C, Chen T-L, Lai C-C and Wu W-C. 20150401. Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. : Eye (London, England).

Harvard

Chen Y., Chen S., Lien R., Shih C., Chao A., Chen K., Hwang Y., Wang N., Chen Y., Lee K., Chuang C., Chen T., Lai C. and Wu W. (20150401). Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. : Eye (London, England).

MLA

Chen Y-H, Chen S-N, Lien R-I, Shih C-P, Chao A-N, Chen K-J, Hwang Y-S, Wang N-K, Chen Y-P, Lee K-H, Chuang C-C, Chen T-L, Lai C-C and Wu W-C. Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. : Eye (London, England). 20150401.